Optimi Health ships psilocybin capsules to Australia in third export Jun 29, 2026 11:37AM
Optimi Health ships psilocybin capsules to Australia in third export Jun 29, 2026 09:01AM
OPTIMI Health adds 1mg and 2mg psilocybin doses for clinical research Jun 16, 2026 08:33AM
Optimi Health secures ibogaine supply for drug development Jun 8, 2026 12:56PM
Optimi Health secures ibogaine supply for drug development Jun 8, 2026 08:02AM


Jun 2, 2026 07:31AM Optimi Health completes psilocybin production for Australian market
May 29, 2026 11:16AM Australia expands psychedelic therapy access with updated prescriber rules
May 29, 2026 08:41AM Optimi Health acknowledges expanded psychedelic therapy access in Australia
May 26, 2026 07:00AM Optimi Health Advances Highest-Purity Natural Psilocybin Extract to Date
May 21, 2026 01:09PM Optimi Health closes $15 million public offering for NASDAQ listing
May 21, 2026 01:07PM Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering
May 20, 2026 08:10AM Optimi Health prices $15 million public offering, lists on NASDAQ
May 20, 2026 08:00AM Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
May 19, 2026 08:52AM Optimi Health files for $20 million US IPO on Nasdaq
Mar 16, 2026 07:03AM Optimi Health launches US public offering ahead of proposed Nasdaq listing